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Abstract 
Review on t(X;11)(q28;p15), with data on the genes 
involved 
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Clinics and pathology 
Disease 
Therapy-related acute myeloid leukemia ( M4 
AML) 
Epidemiology 
Only one case to date: a 73-year-old female patient. 
Cytogenetics 
Cytogenetics morphological 
It is a semi-cryptic translocation, not visible with 
conventional cytogenetics alone and identified as a 
partner in the translocation after FISH technique 
with the NUP98 probe and the telomeric probe 
RP11-479B17 in the first reported case (Romana et 
al, 2006). 
Additional anomalies 
The patient showed a complex karyotype with a 
t(5;12)(q11;p13) as the only one chromosomal 
aberration observed in the stemline and a der(11) 
chromosome in two sidelines. (Romana et al, 2006). 
Genes involved and 
proteins 
HMGB3 (high mobility group box 3) 
Location 
Xq28 
Protein 
HMGB3 encodes a member of a family of proteins 
containing one or more high mobility group (HMG) 
DNA-binding motifs. The protein plays an important 
role in maintaining stem cell populations, and may 
be aberrantly expressed in tumor cells. 
NUP98 (nucleoporin 98 kDa) 
Location 
11p15.4 
Protein 
NUP98 belongs to the nucleoporin gene family and 
encodes a 186 kDa precursor protein that undergoes 
autoproteolytic cleavage to produce a 98 kDa 
nucleoporin and 96 kDa nucleoporin.  The 98 kDa 
nucleoporin contains a Gly-Leu-Phe-Gly (GLGF) 
repeat domain and participates in many cellular 
processes including nuclear import/export, mitotic 
progression, and regulation of gene expression. The 
96 kDa nucleoporin is a component of the nuclear 
pore complex. 
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Result of the chromosomal 
anomaly 
Hybrid gene 
Note 
5' NUP98 - 3' HMGB3 
Description 
Nucleotide sequence analyses revealed an in-frame 
fusion of the exon 11 of NUP98 to the exon 2 of 
HMGB3. No reciprocal HMGB3-NUP98 transcript 
could be detected (Petit et al, 2010). 
Fusion protein 
 
Schematic representation of the NUP98/HMGB3 chimeric transcript, the native and chimeric proteins, showing 
the Gly-Leu-Phe-Gly (GLFG) repeats and RNA binding domain of NUP98 and the two high mobility group 
(HMG) boxes of HMGB3. 
Description 
The NUP98-HMGB3 protein is composed of the 
first 422 amino acids of NUP98 fused to the entire 
HMGB3 coding sequence (Petit et al, 2010). 
Oncogenesis 
The NUP98-fusion proteins induce leukemic 
transformation through the upregulation of HOXA 
genes and the Hox cofactor MEIS1. However, in 
mouse model, it has been shown the 
NUP98/HMGB3-expressing blasts upregulate 
HOXA9 only weakly and retain wild-type levels of 
MEIS1. Evidently, the transformation mediated by 
the NUP98/HMGB3 fusion does not involve 
deregulated activity of the canonical HOXA - 
MEIS1 pathway. The ectopic expression of 
HMGB3, as a result of the fusion with NUP98, can 
bypass the requirement of a concomitant HOXA9 
and MEIS1 misregulation in human malignancy. It 
seems that the several transformation pathways 
might be involved in the leukemogenic properties of 
NUP98 fusions. NUP98/HMGB3 is the first 
example of a NUP98 leukemogenic fusion whose 
expression is not associated with a strong HOXA and 
concomitant MEIS1 expression (Petit et al, 2010). 
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